Menu Back toIBM Innovation Theater: Embracing Hybrid - How New Technologies, Synergized with Proven Solutions, Will Shape the Journey to Commonplace Decentralized Trials

DIA 2021 Global Annual Meeting

IBM Innovation Theater: Embracing Hybrid - How New Technologies, Synergized with Proven Solutions, Will Shape the Journey to Commonplace Decentralized Trials

Session Chair(s)

IBM Watson Health

IBM Watson Health

  • United States
While all eyes are on decentralized trial technologies to improve patient centricity, it's important to recognize the critical role that hybrid trials plays as our industry is still adapting to changes from the past two years. Join IBM Watson Health to learn how IBM clinical development users have leveraged both new decentralized trial technologies and proven cloud-based solutions to manage highly-successful hybrid trials with record-breaking cycle time.

Speaker(s)

Walker Bradham

Walker Bradham

  • Product Leader, IBM Clinical Development
  • IBM Watson Health, United States
Wes Fishburne

Wes Fishburne

  • Product Manager, IBM Clinical Development
  • IBM Watson Health, United States
Mark Laney

Mark Laney

  • Global Manager, Sales Engineering
  • IBM Watson Health, United States